The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Molecular screening for cancer treatment optimization (MOSCATO 01) in pediatric patients: First feasibility results of a prospective molecular stratification trial.
Birgit Geoerger
No relevant relationships to disclose
Frederic Deschamps
No relevant relationships to disclose
Stephanie Puget
No relevant relationships to disclose
Valerie Koubi-Pick
No relevant relationships to disclose
Ludovic Lacroix
No relevant relationships to disclose
Philippe Vielh
No relevant relationships to disclose
Pascale Varlet
Employment or Leadership Position - Novartis (I)
Thierry De Baere
No relevant relationships to disclose
Francisco Bautista
No relevant relationships to disclose
Leslie Baker Tsambou
No relevant relationships to disclose
Dominique Valteau Couanet
No relevant relationships to disclose
Maud Ngo-camus
No relevant relationships to disclose
Marie-Cécile Le Deley
No relevant relationships to disclose
Veronique Minard-Colin
No relevant relationships to disclose
Jacques Grill
No relevant relationships to disclose
Laurence Brugieres
No relevant relationships to disclose
Christelle Dufour
No relevant relationships to disclose
Nathalie Gaspar
No relevant relationships to disclose
Gilles Vassal
No relevant relationships to disclose
Jean-Charles Soria
Honoraria - Sanofi
Research Funding - Sanofi